Farther-Finance-Advisors

Filing Details

13F-HR • 2025-03-31
Report Date
2025-03-31
Filing Date
2025-04-14
Total Holdings
4,304
Total Value
3918135517
Accession Number
0001992825-25-000004
Form Type
13F-HR
Manager Name
Farther-Finance-Advisors
Data Enrichment
71% identified
3,043 identified1,261 unidentified

Holdings

4,304 positions • $3.9B total value
Manager:
Search and click to pin securities to the top
Page 211 of 216
Carter Bankshares, Inc.
Shares:1
Value:$16
% of Portfolio:0.0% ($16/$3.9B)
EZCORP INC
Shares:1
Value:$16
% of Portfolio:0.0% ($16/$3.9B)
Bionano Genomics, Inc.
Shares:5
Value:$16
% of Portfolio:0.0% ($16/$3.9B)
LEVI STRAUSS & CO
Shares:1
Value:$16
% of Portfolio:0.0% ($16/$3.9B)
Anika Therapeutics, Inc.
Shares:1
Value:$15
% of Portfolio:0.0% ($15/$3.9B)
National Energy Services Reunited Corp.
Shares:2
Value:$15
% of Portfolio:0.0% ($15/$3.9B)
LCNB CORP
Shares:1
Value:$15
% of Portfolio:0.0% ($15/$3.9B)
GT Biopharma, Inc.
Shares:6
Value:$14
% of Portfolio:0.0% ($14/$3.9B)
Inhibrx Biosciences, Inc.
Shares:1
Value:$14
% of Portfolio:0.0% ($14/$3.9B)
ModivCare Inc
Shares:10
Value:$14
% of Portfolio:0.0% ($14/$3.9B)
Pulmonx Corp
Shares:2
Value:$14
% of Portfolio:0.0% ($14/$3.9B)
Viridian Therapeutics, Inc.\DE
Shares:1
Value:$13
% of Portfolio:0.0% ($13/$3.9B)
fuboTV Inc. /FL
Shares:4
Value:$12
% of Portfolio:0.0% ($12/$3.9B)
Aspire Biopharma Holdings, Inc.
Shares:20
Value:$12
% of Portfolio:0.0% ($12/$3.9B)
Northwest Bancshares, Inc.
Shares:1
Value:$12
% of Portfolio:0.0% ($12/$3.9B)
UroGen Pharma Ltd.
Shares:1
Value:$11
% of Portfolio:0.0% ($11/$3.9B)
OmniAb, Inc.
Shares:5
Value:$11
% of Portfolio:0.0% ($11/$3.9B)
PLBY Group, Inc.
Shares:10
Value:$11
% of Portfolio:0.0% ($11/$3.9B)
09075P204
Shares:5
Value:$10
% of Portfolio:0.0% ($10/$3.9B)
674434303
Shares:3
Value:$10
% of Portfolio:0.0% ($10/$3.9B)